demonstrated a cost-savings benefit with the use of dalbavancin, though it did not reach statistical significance due to low overall patient numbers in the trial [ 66 ].
1
—
—
demonstrated a cost-savings benefit with the use of dalbavancin, though it did not reach statistical significance due to low overall patient numbers in the trial [ 66 ].